Search

everythinglearnresearchcommunity

for

Search:↓

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Women with irregular periods have a higher risk of heart disease.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

Women also use 5α-reductase inhibitors, and their effects differ from men.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Androgenetic alopecia in women needs more research and better management strategies.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

WAA-QOL measures impact of hair loss on women's well-being.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Finasteride may help some women with hair loss, but better options exist.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Early treatment helps stop hair loss in women of color.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Higher serum ferritin levels than currently used might be needed to rule out iron deficiency in women with hair loss.